Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8865732 Heterocyclic compounds and uses thereof

Patent 8865732 was granted and assigned to Novartis on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8865732

Patent Inventor Names

Yongjin Xu0

Zheng Chen0

Zilin Huang0

Maureen McKenna0

Aaron Smith0

Cynthia Shafer0

Daniel Poon0

Jeff Jin0

...

Date of Patent

October 21, 2014

Patent Application Number

13396339

Date Filed

February 14, 2012

Patent Citations Received

‌

US Patent 11866432 Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors

‌

US Patent 11981671 Bicyclic pyrazolyl amines as CDK2 inhibitors

‌

US Patent 11976073 Bicyclic amines as CDK2 inhibitors

‌

US Patent 11851426 Bicyclic amines as CDK2 inhibitors

‌

US Patent 11919904 Sulfonylamide compounds as CDK2 inhibitors

Patent Primary Examiner

‌

Noble Jarrell

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8865732 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API